We recently compiled a list of the 12 Best Dividend Stocks Under $30. In this article, we are going to take a look at where ...

The first full week of February brings a packed earnings calendar, featuring major names across sectors. Tech giants Amazon ...

Concord Wealth Partners boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 253.0% during the fourth quarter, according to the company in its most recent filing with the ...

Stay ahead of the curve with Seeking Alpha's Catalyst Watch - a breakdown of next week's events that may impact stock prices.

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Shares in Amazon ( AMZN) are up nearly 46% over the past year, with the stock hitting a record high closing price of $238.15 (£191.84) on Tuesday. A key focus in Amazon's ( AMZN) upcoming results will ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The ...

Rating for Harmony Biosciences stock jumped into a new percentile Thursday, with an increase from 70 to 83. This proprietary rating tracks market leadership by showing how a stock's price movement ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Pfizer (NYSE:PFE – Get Free Report) had its price objective decreased by equities research analysts at Citigroup from $30.00 ...

Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price traded down 0.6% during trading on Tuesday after Citigroup lowered their price target on the stock from $30.00 to $29.00. Citigroup currently has ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.